Companies/Auxly Cannabis Group Inc.

Company profile

Auxly Cannabis Group Inc.

OTC: CBWTF · Healthcare · Drug Manufacturers - Specialty & Generic

Canadian filerHQ Toronto, ONReports USD

#338 of 1,394 Healthcare companies by revenue68th-percentile growth

EA Score

76B+

FH 81DQ —GM 65SS 64

v0.1 · 45/100 weight · provisional

↑ return on assets, net margin · ↓ listing tenure, disclosure history

Methodology →

Revenue TTM

$106.6M

Rev growth YoY (TTM)

+14.4%

Net income (FY)

$29.9M

Employees

388

Market cap

$174.7M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$108.3M151.4M CAD2025

Net income$29.9M41.8M CAD2025

Operating income-$17.5M-24.4M CAD2025

Total assets$198.0M271.4M CAD2025

Liabilities$68.6M94.0M CAD2025

Equity$129.5M177.4M CAD2025

Revenue trend

FY2018 – FY2025 · USD

$576.5k

FY18

$6.3M

FY19

$34.8M

FY20

$66.9M

FY21

$72.6M

FY22

$74.9M

FY23

$89.3M

FY24

$108.3M

FY25

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Auxly Cannabis Group Inc. booked $108.3M in FY2025 revenue, growing 21% year over year — faster than most Healthcare companies we track, at a 27.6% net margin.

Peers · Healthcare

Stereotaxis, Inc.55C NervGen Pharma Corp. Common stock——Aurora Cannabis Inc.——Coherus Oncology, Inc.62C

Key facts

CEOHugo Alves

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersToronto, ON

ExchangeOTC: CBWTF

Employees388

IPO date2017-04-07

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.